Siepmann F, Siepmann J, Walther M, MacRae R J, Bodmeier R
College of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169 Berlin, Germany.
J Control Release. 2005 Jul 20;105(3):226-39. doi: 10.1016/j.jconrel.2005.03.028.
Blends of aqueous dispersions of a water-insoluble and an enteric polymer, namely ethyl cellulose:hydroxypropyl methylcellulose acetate succinate (EC:HPMCAS) and ethyl cellulose:methacrylic acid ethyl acrylate copolymer (EC:Eudragit L), were used as coating materials to control theophylline release from matrix pellets. Varying the polymer blend ratio, broad ranges of drug release patterns were obtained at low as well as at high pH. Interestingly, the resulting release profiles were rather similar for both types of blends in 0.1 M HCl, whereas significant differences were observed in phosphate buffer pH 7.4. Surprisingly, drug release at high pH was much slower for EC:HPMCAS blends compared to EC:Eudragit L blends, although HPMCAS leached out more rapidly (and to a higher extent) from the film coatings than Eudragit L. To explain these phenomena and to better understand the underlying drug release mechanisms, thin polymeric films of identical composition as the pellet coatings were prepared and physicochemically characterized before and upon exposure to the release media. Importantly, the polymer particle size was identified to be a very crucial formulation parameter, determining the resulting film coating structure and properties. The Eudragit L particles are much smaller than the HPMCAS particles (nano- vs. micrometer size range) and, thus, more effectively hinder the formation of a continuous and mechanically stable EC network. Consequently, the EC structures remaining after enteric polymer leaching at high pH are mechanically much weaker in the case of Eudragit L. Upon exposure to phosphate buffer, water-filled cracks are formed, through which the drug rapidly diffuses out. In contrast, the EC structures remaining upon HPMCAS leaching are mechanically stronger and drug release is controlled by diffusion through the polymeric remnants.
水不溶性聚合物和肠溶聚合物的水分散体混合物,即乙基纤维素:羟丙基甲基纤维素醋酸琥珀酸酯(EC:HPMCAS)和乙基纤维素:甲基丙烯酸乙酯-丙烯酸乙酯共聚物(EC:Eudragit L),被用作包衣材料来控制茶碱从基质微丸中的释放。通过改变聚合物共混比例,在低pH和高pH条件下均获得了广泛的药物释放模式。有趣的是,两种类型的混合物在0.1 M HCl中的释放曲线相当相似,而在pH 7.4的磷酸盐缓冲液中观察到显著差异。令人惊讶的是,与EC:Eudragit L混合物相比,EC:HPMCAS混合物在高pH下的药物释放要慢得多,尽管HPMCAS从薄膜包衣中沥出的速度更快(且程度更高)。为了解释这些现象并更好地理解潜在的药物释放机制,制备了与微丸包衣组成相同的聚合物薄膜,并在暴露于释放介质之前和之后进行了物理化学表征。重要的是,聚合物粒径被确定为一个非常关键的制剂参数,它决定了最终的薄膜包衣结构和性能。Eudragit L颗粒比HPMCAS颗粒小得多(纳米级与微米级尺寸范围),因此更有效地阻碍了连续且机械稳定的EC网络的形成。因此,在高pH下肠溶聚合物沥出后剩余的EC结构在Eudragit L的情况下机械强度要弱得多。暴露于磷酸盐缓冲液后,会形成充满水的裂缝,药物通过这些裂缝迅速扩散出去。相比之下,HPMCAS沥出后剩余的EC结构机械强度更强,药物释放通过聚合物残余物的扩散来控制。